|
Valoración de DCF de Rapid Micro Biosystems, Inc. (RPID)
US | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Rapid Micro Biosystems, Inc. (RPID) Bundle
¡Maximice la eficiencia y mejore la precisión con nuestra calculadora DCF Rapid Micro Biosystems, Inc. (RPID)! Utilizando datos reales de micro biosistemas rápidos y suposiciones ajustables, esta herramienta le permite pronosticar, analizar y valorar Rapid Micro Biosystems, Inc. como un inversor experimentado.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16.5 | 16.1 | 23.2 | 17.1 | 22.5 | 25.2 | 28.1 | 31.4 | 35.1 | 39.3 |
| Revenue Growth, % | 0 | -2.63 | 44.5 | -26.25 | 31.44 | 11.76 | 11.76 | 11.76 | 11.76 | 11.76 |
| EBITDA | -16.9 | -32.0 | -45.8 | -60.4 | -53.8 | -25.2 | -28.1 | -31.4 | -35.1 | -39.3 |
| EBITDA, % | -102.16 | -199.02 | -197.15 | -352.43 | -238.72 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 1.5 | 1.5 | 1.6 | 4.0 | 3.1 | 3.1 | 3.5 | 3.9 | 4.4 | 4.9 |
| Depreciation, % | 9.08 | 9.33 | 7.01 | 23.23 | 13.79 | 12.49 | 12.49 | 12.49 | 12.49 | 12.49 |
| EBIT | -18.4 | -33.5 | -47.4 | -64.4 | -56.9 | -25.2 | -28.1 | -31.4 | -35.1 | -39.3 |
| EBIT, % | -111.25 | -208.35 | -204.17 | -375.66 | -252.51 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 12.5 | 45.1 | 193.5 | 108.6 | 92.1 | 23.9 | 26.7 | 29.9 | 33.4 | 37.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 4.9 | 5.8 | 5.4 | 5.5 | 5.6 | 7.3 | 8.2 | 9.2 | 10.2 | 11.5 |
| Account Receivables, % | 29.79 | 35.98 | 23.25 | 31.99 | 24.79 | 29.16 | 29.16 | 29.16 | 29.16 | 29.16 |
| Inventories | 5.8 | 9.0 | 15.7 | 21.2 | 20.0 | 17.5 | 19.5 | 21.8 | 24.4 | 27.2 |
| Inventories, % | 34.84 | 55.76 | 67.45 | 123.66 | 88.64 | 69.34 | 69.34 | 69.34 | 69.34 | 69.34 |
| Accounts Payable | 3.2 | 4.5 | 3.9 | 5.4 | 2.0 | 5.3 | 5.9 | 6.6 | 7.4 | 8.2 |
| Accounts Payable, % | 19.45 | 27.79 | 16.98 | 31.68 | 8.76 | 20.93 | 20.93 | 20.93 | 20.93 | 20.93 |
| Capital Expenditure | -1.7 | -.7 | -3.2 | -6.7 | -1.8 | -3.8 | -4.3 | -4.8 | -5.3 | -6.0 |
| Capital Expenditure, % | -10.27 | -4.29 | -13.85 | -39.34 | -8.19 | -15.19 | -15.19 | -15.19 | -15.19 | -15.19 |
| Tax Rate, % | -0.05911969 | -0.05911969 | -0.05911969 | -0.05911969 | -0.05911969 | -0.05911969 | -0.05911969 | -0.05911969 | -0.05911969 | -0.05911969 |
| EBITAT | -18.7 | -33.6 | -47.5 | -63.8 | -56.9 | -25.1 | -28.1 | -31.4 | -35.1 | -39.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -26.4 | -35.6 | -55.9 | -70.6 | -58.0 | -21.8 | -31.1 | -34.8 | -38.9 | -43.5 |
| WACC, % | 8.77 | 8.77 | 8.77 | 8.77 | 8.77 | 8.77 | 8.77 | 8.77 | 8.77 | 8.77 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -129.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -44 | |||||||||
| Terminal Value | -655 | |||||||||
| Present Terminal Value | -430 | |||||||||
| Enterprise Value | -560 | |||||||||
| Net Debt | -17 | |||||||||
| Equity Value | -543 | |||||||||
| Diluted Shares Outstanding, MM | 43 | |||||||||
| Equity Value Per Share | -12.61 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real RPID financials.
- Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effects of your inputs on Rapid Micro Biosystems’ valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- 🔍 Real-Life RPID Financials: Pre-filled historical and projected data for Rapid Micro Biosystems, Inc. (RPID).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Rapid Micro Biosystems’ intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Rapid Micro Biosystems’ valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file for Rapid Micro Biosystems, Inc. (RPID).
- Step 2: Review the pre-filled financial data and forecasts for Rapid Micro Biosystems.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you modify your assumptions.
- Step 5: Evaluate the outputs and leverage the results for your investment strategies.
Why Choose This Calculator for Rapid Micro Biosystems, Inc. (RPID)?
- All-in-One Solution: Combines DCF, WACC, and financial ratio analyses tailored for RPID.
- Adjustable Parameters: Modify the highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes RPID’s intrinsic value and Net Present Value.
- Preloaded Information: Access historical and projected data for precise evaluations.
- Expert-Level Tool: Perfect for financial analysts, investors, and business advisors focusing on RPID.
Who Should Use This Product?
- Healthcare Professionals: Implement advanced technologies for microbial detection and monitoring.
- Laboratory Managers: Optimize workflow and enhance accuracy in microbial testing processes.
- Investors: Evaluate the growth potential of Rapid Micro Biosystems, Inc. (RPID) in the biotech sector.
- Researchers and Academics: Leverage innovative methodologies for studies in microbiology and diagnostics.
- Quality Assurance Teams: Ensure compliance and reliability in microbial quality control procedures.
What the Template Contains
- Pre-Filled Data: Includes Rapid Micro Biosystems, Inc.'s (RPID) historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations tailored for (RPID).
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs specific to (RPID).
- Key Financial Ratios: Analyze Rapid Micro Biosystems, Inc.'s (RPID) profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease for (RPID).
- Clear Dashboard: Charts and tables summarizing key valuation results for Rapid Micro Biosystems, Inc. (RPID).